Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function.
about
Molecular cloning and characterization of a human uronyl 2-sulfotransferase that sulfates iduronyl and glucuronyl residues in dermatan/chondroitin sulfateFGF-10 and specific structural elements of dermatan sulfate size and sulfation promote maximal keratinocyte migration and cellular proliferationReceptor specificity of the fibroblast growth factor family. The complete mammalian FGF familyAntiangiogenic mechanisms and factors in breast cancer treatmentExtracellular Matrix and Dermal Fibroblast Function in the Healing WoundMMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activationPivotal role for decorin in angiogenesisSpecificities of three distinct human chondroitin/dermatan N-acetylgalactosamine 4-O-sulfotransferases demonstrated using partially desulfated dermatan sulfate as an acceptor: implication of differential roles in dermatan sulfate biosynthesisElongated dermatan sulphate in post-inflammatory healing skin distributes among collagen fibrils separated by enlarged interfibrillar gapsEnhancement of scleral macromolecular permeability with prostaglandinsDifferential expression of syndecan-1 mediates cationic nanoparticle toxicity in undifferentiated versus differentiated normal human bronchial epithelial cellsDecorin mimic regulates platelet-derived growth factor and interferon-γ stimulation of vascular smooth muscle cellsCollagen-binding peptidoglycans inhibit MMP mediated collagen degradation and reduce dermal scarringExogenous addition of a C-xylopyranoside derivative stimulates keratinocyte dermatan sulfate synthesis and promotes migrationBasic FGF mediates an immediate response of articular cartilage to mechanical injury.A disintegrin and metalloproteinase 17 (ADAM17) mediates inflammation-induced shedding of syndecan-1 and -4 by lung epithelial cellsDermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1.Impaired elastogenesis in Hurler disease: dermatan sulfate accumulation linked to deficiency in elastin-binding protein and elastic fiber assembly.Marine polysaccharides: a source of bioactive molecules for cell therapy and tissue engineeringSerpina3n attenuates granzyme B-mediated decorin cleavage and rupture in a murine model of aortic aneurysm.A novel eliminase from a marine bacterium that degrades hyaluronan and chondroitin sulfate.Mesoglycan: clinical evidences for use in vascular diseases.A role for decorin in controlling proliferation, adhesion, and migration of murine embryonic fibroblastsDecorin is produced by capillary endothelial cells in inflammation-associated angiogenesis.FGF-2 regulation of neurogenesis in adult hippocampus after brain injurySugar-coating wound repair: a review of FGF-10 and dermatan sulfate in wound healing and their potential application in burn wounds.Pseudomonas aeruginosa elastase cleaves a C-terminal peptide from human thrombin that inhibits host inflammatory responsesProbing structural selectivity of synthetic heparin binding to Stabilin protein receptorsGenetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesisPharmacological modulation of human mesenchymal stem cell chondrogenesis by a chemically oversulfated polysaccharide of marine origin: potential application to cartilage regenerative medicineFGF-2 regulates neurogenesis and degeneration in the dentate gyrus after traumatic brain injury in mice.Differential expression of decorin by human malignant and benign vascular tumors.Unusual glycosaminoglycans from a deep sea hydrothermal bacterium improve fibrillar collagen structuring and fibroblast activities in engineered connective tissues.Biological functions of iduronic acid in chondroitin/dermatan sulfate.Recent advances in the structural study of functional chondroitin sulfate and dermatan sulfate in health and disease.Correlation between expression and differentiation of endocan in colorectal cancer.A decorin-deficient matrix affects skin chondroitin/dermatan sulfate levels and keratinocyte function.Brittlestars contain highly sulfated chondroitin sulfates/dermatan sulfates that promote fibroblast growth factor 2-induced cell signaling.Molecular engineering of glycosaminoglycan chemistry for biomolecule delivery.Epidermal transformation leads to increased perlecan synthesis with heparin-binding-growth-factor affinity.
P2860
Q22009136-5F4AFCF6-8C1D-4EF8-9AAF-6B5A4DEDB406Q24317993-67AA3638-9B38-458A-9F99-A6141511AA1DQ24676527-FB77D54D-2597-440C-9B24-88F531C371F3Q26751226-FB3233CF-1C94-4542-9533-389EF2A1D918Q26753838-8290A4C6-65E2-479A-B3F5-FD416E4E27D5Q27345120-683FCF0A-B4A8-4CC2-AAB7-2EE6C0926514Q28085303-4D6D7462-04AF-430A-9F57-2D6B3CF11C0FQ28185488-63349723-E6C5-4998-95A6-474A50DCD96CQ28345223-10CAB55D-A89E-476A-9576-2DEF5800A7F9Q28345276-D98A59CB-FD97-4F31-B74B-1FFB969505C9Q28394538-03A22E0E-AD4C-40C6-9CD1-204ED6C544B7Q28658459-321B5C44-3FCB-4835-9D66-D6E108FAF996Q28742746-9BC96A0C-30BF-422E-9E7B-1107BDDD8ED1Q28744232-A8326AB3-7152-4A96-83F1-5C9D443767AAQ31063362-C4EB77E9-9A07-46FD-9822-7385A0285B0DQ33581409-8E2BA69B-39A2-48D7-8BC8-2C171E946844Q33851916-A5B91A79-06B2-4124-9CA7-F9B1A31D206DQ33892206-E9467EA1-A3FD-4C1A-BD0D-D84B9E9F74FBQ34087545-A57ADBF2-38F2-4B9C-8A75-B96E41F9E878Q34214463-44185227-8F04-45E8-A8AF-F11C3468DAD4Q34283564-C2FA8188-0A16-448A-ABEC-45092C4A86ACQ34340567-B6206244-64A2-41B0-A843-E7E80FE7AA21Q35413620-128E23A0-CF95-4382-9150-F05A95E633B9Q35746282-14206FFE-707A-4B0E-8BF9-5225642B95D5Q35900346-6016B2B5-E2E5-4DCF-9880-CE48653300D3Q35947477-7066E413-BBD2-4176-AC3F-C61CFC736D58Q36018223-452F8DCB-E4AA-4C6A-B466-D77611A904A8Q36033096-573B10B9-86BF-4210-AE75-3DA8640A1868Q36119681-09CA1A2B-6234-437B-B7CA-00951085F73FQ36236903-B826E5AD-8B3B-4AD5-A56E-CDFB901030D9Q36259459-1B1B20D7-31E4-488A-AEA9-2EE9C70C7553Q36725204-9040EDF1-9562-4880-9C40-7CB62AD9C958Q36994259-B0E27399-4C91-4887-BB1D-2D5B27821E40Q37029047-46219474-33DB-4480-846A-4C0E891CF8C2Q37228522-20D8F8C5-BF44-4F92-9E93-C2B0854D9C31Q37316926-EAEEC78A-4D35-46A9-A3E3-0409D909A711Q37513506-4095DB1F-457C-4CC6-A3D7-090CBA3AE459Q37532995-DC6667DF-889C-4DB9-9EBE-EDBF56930CE4Q38152204-BCD6F1DA-D34C-4AA1-814E-C24B36583AC2Q38302299-6A6C7AB1-BDD6-4948-BF00-987DE69B5601
P2860
Dermatan sulfate released after injury is a potent promoter of fibroblast growth factor-2 function.
description
1998 nî lūn-bûn
@nan
1998 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Dermatan sulfate released afte ...... last growth factor-2 function.
@ast
Dermatan sulfate released afte ...... last growth factor-2 function.
@en
Dermatan sulfate released afte ...... last growth factor-2 function.
@nl
type
label
Dermatan sulfate released afte ...... last growth factor-2 function.
@ast
Dermatan sulfate released afte ...... last growth factor-2 function.
@en
Dermatan sulfate released afte ...... last growth factor-2 function.
@nl
prefLabel
Dermatan sulfate released afte ...... last growth factor-2 function.
@ast
Dermatan sulfate released afte ...... last growth factor-2 function.
@en
Dermatan sulfate released afte ...... last growth factor-2 function.
@nl
P2093
P356
P1476
Dermatan sulfate released afte ...... blast growth factor-2 function
@en
P2093
E Eriksson
R A Dorschner
P304
28116-28121
P356
10.1074/JBC.273.43.28116
P407
P577
1998-10-01T00:00:00Z